{"id":30316,"date":"2025-01-20T10:59:32","date_gmt":"2025-01-20T09:59:32","guid":{"rendered":"https:\/\/ggba.swiss\/medtech-aspivix-secures-eur-1-95-million-in-crowdfunding\/"},"modified":"2025-01-20T11:08:24","modified_gmt":"2025-01-20T10:08:24","slug":"la-medtech-aspivix-decroche-eur-195-million-dans-le-cadre-dun-crowdfunding","status":"publish","type":"post","link":"https:\/\/ggba.swiss\/fr\/la-medtech-aspivix-decroche-eur-195-million-dans-le-cadre-dun-crowdfunding\/","title":{"rendered":"La medtech Aspivix d\u00e9croche EUR 1,95 million dans le cadre d&rsquo;un crowdfunding"},"content":{"rendered":"\n<p>Implant\u00e9e dans le canton de Vaud, la soci\u00e9t\u00e9 <a href=\"https:\/\/www.aspivix.com\/fr\/\">Aspivix<\/a> r\u00e9volutionne les pratiques gyn\u00e9cologiques avec Carevix\u2122, un dispositif con\u00e7u pour remplacer les pinces de Pozzi traditionnelles. L&rsquo;appareil utilise une aspiration douce pour stabiliser le col de l&rsquo;ut\u00e9rus, ce qui r\u00e9duit consid\u00e9rablement la douleur, les saignements et le stress associ\u00e9s aux proc\u00e9dures gyn\u00e9cologiques. Carevix\u2122 est homologu\u00e9 par la FDA pour le march\u00e9 am\u00e9ricain, porte le marquage CE pour l&rsquo;Union europ\u00e9enne et est approuv\u00e9 au Royaume-Uni et au Br\u00e9sil. D\u00e9j\u00e0 utilis\u00e9 dans un r\u00e9seau de cliniques aux \u00c9tats-Unis, le dispositif est pr\u00eat \u00e0 \u00eatre adopt\u00e9 \u00e0 plus grande \u00e9chelle.<\/p>\n\n\n\n<p>L&rsquo;aventure a commenc\u00e9 par une conversation entre les fr\u00e8res Julien Finci, ing\u00e9nieur, et David Finci, gyn\u00e9cologue, qui ont identifi\u00e9 l&rsquo;inconfort caus\u00e9 par les pinces de Pozzi comme un domaine critique \u00e0 am\u00e9liorer. Avec l&rsquo;expertise du cofondateur Mathieu Horras, Carevix\u2122 a \u00e9t\u00e9 d\u00e9velopp\u00e9 comme une alternative conviviale pour les patientes. Prot\u00e9g\u00e9 par plusieurs brevets, le dispositif change la donne pour les soins gyn\u00e9cologiques, alliant simplicit\u00e9 et technologie de pointe.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\">L&rsquo;innovation suisse au service des patients<\/h4>\n\n\n\n<p>La croissance d&rsquo;Aspivix est appuy\u00e9e par l&rsquo;\u00e9cosyst\u00e8me dynamique de la Health Valley de Suisse occidentale. Les partenariats avec le <a href=\"https:\/\/www.chuv.ch\/fr\/chuv-home\">CHUV<\/a>, l&rsquo;<a href=\"https:\/\/www.epfl.ch\/\">EPFL<\/a> et l&rsquo;<a href=\"https:\/\/heig-vd.ch\/\">HEIG-VD<\/a> ont jou\u00e9 un r\u00f4le crucial dans le d\u00e9veloppement du produit et la validation clinique. Soutenue par des initiatives telles qu&rsquo;Innosuisse et Innovaud, l&rsquo;entreprise a attir\u00e9 des collaborations strat\u00e9giques, y compris un partenariat avec Bayer en 2024.<\/p>\n\n\n\n<p>Les r\u00e9alisations de l&rsquo;entreprise ont obtenu une reconnaissance internationale, le magazine <em>Time<\/em> ayant nomm\u00e9 Carevix\u2122 parmi les 200 meilleures inventions de 2024. La campagne de crowdfunding permettra \u00e0 Aspivix d&rsquo;augmenter sa production et d&rsquo;\u00e9tendre sa pr\u00e9sence sur des march\u00e9s cl\u00e9s.<\/p>\n\n\n\n<p>L&rsquo;initiative de crowdfunding d&rsquo;Aspivix a attir\u00e9 85 investisseurs \u00e0 ce jour, d\u00e9montrant un large soutien \u00e0 sa mission d&rsquo;am\u00e9liorer les soins de sant\u00e9 des femmes. \u00c0 mesure que la campagne progresse, Aspivix s&rsquo;engage \u00e0 tirer parti de sa technologie innovante pour apporter confort et dignit\u00e9 aux patientes du monde entier.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>La start-up Aspivix a lev\u00e9 EUR 1,95 million par le biais d&rsquo;une campagne de crowdfunding pour permettre la commercialisation de son dispositif gyn\u00e9cologique innovant, Carevix\u2122. La campagne, h\u00e9berg\u00e9e sur la plateforme Capital Cell, vise \u00e0 atteindre un objectif de EUR 2,15 millions d&rsquo;ici le 15 mars 2025.<\/p>\n","protected":false},"author":6,"featured_media":30313,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"mc4wp_mailchimp_campaign":[],"footnotes":""},"categories":[843],"tags":[1148,1188,1181,1163],"class_list":["post-30316","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sciences-de-la-vie","tag-financing-fr-2","tag-healthcare-fr-2","tag-medical-devices-fr","tag-medtech-fr-2"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Aspivix d\u00e9croche EUR 1,95 million dans le cadre d&#039;un crowdfunding<\/title>\n<meta name=\"description\" content=\"La start-up Aspivix a lev\u00e9 EUR 1,95 million pour permettre la commercialisation de son dispositif gyn\u00e9cologique innovant, Carevix\u2122.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ggba.swiss\/fr\/la-medtech-aspivix-decroche-eur-195-million-dans-le-cadre-dun-crowdfunding\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Aspivix d\u00e9croche EUR 1,95 million dans le cadre d&#039;un crowdfunding\" \/>\n<meta property=\"og:description\" content=\"La start-up Aspivix a lev\u00e9 EUR 1,95 million pour permettre la commercialisation de son dispositif gyn\u00e9cologique innovant, Carevix\u2122.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ggba.swiss\/fr\/la-medtech-aspivix-decroche-eur-195-million-dans-le-cadre-dun-crowdfunding\/\" \/>\n<meta property=\"og:site_name\" content=\"Greater Geneva Bern area\" \/>\n<meta property=\"article:published_time\" content=\"2025-01-20T09:59:32+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-01-20T10:08:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ggba.swiss\/app\/uploads\/2025\/01\/Aspivix-1180x811-1.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"1180\" \/>\n\t<meta property=\"og:image:height\" content=\"811\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Pierre-Yves Oehrli\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Pierre-Yves Oehrli\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ggba.swiss\/fr\/la-medtech-aspivix-decroche-eur-195-million-dans-le-cadre-dun-crowdfunding\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/la-medtech-aspivix-decroche-eur-195-million-dans-le-cadre-dun-crowdfunding\/\"},\"author\":{\"name\":\"Pierre-Yves Oehrli\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"headline\":\"La medtech Aspivix d\u00e9croche EUR 1,95 million dans le cadre d&rsquo;un crowdfunding\",\"datePublished\":\"2025-01-20T09:59:32+00:00\",\"dateModified\":\"2025-01-20T10:08:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/la-medtech-aspivix-decroche-eur-195-million-dans-le-cadre-dun-crowdfunding\/\"},\"wordCount\":375,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/la-medtech-aspivix-decroche-eur-195-million-dans-le-cadre-dun-crowdfunding\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2025\/01\/Aspivix-1180x811-1.jpeg\",\"keywords\":[\"Financing\",\"Healthcare\",\"Medical Devices\",\"Medtech\"],\"articleSection\":[\"Sciences de la vie\"],\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/ggba.swiss\/fr\/la-medtech-aspivix-decroche-eur-195-million-dans-le-cadre-dun-crowdfunding\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ggba.swiss\/fr\/la-medtech-aspivix-decroche-eur-195-million-dans-le-cadre-dun-crowdfunding\/\",\"url\":\"https:\/\/ggba.swiss\/fr\/la-medtech-aspivix-decroche-eur-195-million-dans-le-cadre-dun-crowdfunding\/\",\"name\":\"Aspivix d\u00e9croche EUR 1,95 million dans le cadre d'un crowdfunding\",\"isPartOf\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/la-medtech-aspivix-decroche-eur-195-million-dans-le-cadre-dun-crowdfunding\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/la-medtech-aspivix-decroche-eur-195-million-dans-le-cadre-dun-crowdfunding\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2025\/01\/Aspivix-1180x811-1.jpeg\",\"datePublished\":\"2025-01-20T09:59:32+00:00\",\"dateModified\":\"2025-01-20T10:08:24+00:00\",\"author\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"description\":\"La start-up Aspivix a lev\u00e9 EUR 1,95 million pour permettre la commercialisation de son dispositif gyn\u00e9cologique innovant, Carevix\u2122.\",\"breadcrumb\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/la-medtech-aspivix-decroche-eur-195-million-dans-le-cadre-dun-crowdfunding\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ggba.swiss\/fr\/la-medtech-aspivix-decroche-eur-195-million-dans-le-cadre-dun-crowdfunding\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ggba.swiss\/fr\/la-medtech-aspivix-decroche-eur-195-million-dans-le-cadre-dun-crowdfunding\/#primaryimage\",\"url\":\"https:\/\/ggba.swiss\/app\/uploads\/2025\/01\/Aspivix-1180x811-1.jpeg\",\"contentUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2025\/01\/Aspivix-1180x811-1.jpeg\",\"width\":1180,\"height\":811,\"caption\":\"Le dispositif Carevix\u2122 d'Aspivix offre une alternative transformatrice aux outils gyn\u00e9cologiques traditionnels, r\u00e9duisant l'inconfort des patientes tout en faisant progresser le domaine des soins de sant\u00e9 pour les femmes dans le monde entier. | \u00a9 Aspivix\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ggba.swiss\/fr\/la-medtech-aspivix-decroche-eur-195-million-dans-le-cadre-dun-crowdfunding\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ggba.swiss\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"La medtech Aspivix d\u00e9croche EUR 1,95 million dans le cadre d&#8217;un crowdfunding\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\",\"url\":\"https:\/\/staging.ggba.swiss\/en\/\",\"name\":\"Greater Geneva Bern area\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\",\"name\":\"Pierre-Yves Oehrli\",\"url\":\"https:\/\/ggba.swiss\/fr\/author\/pierre-yves-oehrli\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Aspivix d\u00e9croche EUR 1,95 million dans le cadre d'un crowdfunding","description":"La start-up Aspivix a lev\u00e9 EUR 1,95 million pour permettre la commercialisation de son dispositif gyn\u00e9cologique innovant, Carevix\u2122.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ggba.swiss\/fr\/la-medtech-aspivix-decroche-eur-195-million-dans-le-cadre-dun-crowdfunding\/","og_locale":"fr_FR","og_type":"article","og_title":"Aspivix d\u00e9croche EUR 1,95 million dans le cadre d'un crowdfunding","og_description":"La start-up Aspivix a lev\u00e9 EUR 1,95 million pour permettre la commercialisation de son dispositif gyn\u00e9cologique innovant, Carevix\u2122.","og_url":"https:\/\/ggba.swiss\/fr\/la-medtech-aspivix-decroche-eur-195-million-dans-le-cadre-dun-crowdfunding\/","og_site_name":"Greater Geneva Bern area","article_published_time":"2025-01-20T09:59:32+00:00","article_modified_time":"2025-01-20T10:08:24+00:00","og_image":[{"width":1180,"height":811,"url":"https:\/\/ggba.swiss\/app\/uploads\/2025\/01\/Aspivix-1180x811-1.jpeg","type":"image\/jpeg"}],"author":"Pierre-Yves Oehrli","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Pierre-Yves Oehrli","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ggba.swiss\/fr\/la-medtech-aspivix-decroche-eur-195-million-dans-le-cadre-dun-crowdfunding\/#article","isPartOf":{"@id":"https:\/\/ggba.swiss\/fr\/la-medtech-aspivix-decroche-eur-195-million-dans-le-cadre-dun-crowdfunding\/"},"author":{"name":"Pierre-Yves Oehrli","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"headline":"La medtech Aspivix d\u00e9croche EUR 1,95 million dans le cadre d&rsquo;un crowdfunding","datePublished":"2025-01-20T09:59:32+00:00","dateModified":"2025-01-20T10:08:24+00:00","mainEntityOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/la-medtech-aspivix-decroche-eur-195-million-dans-le-cadre-dun-crowdfunding\/"},"wordCount":375,"commentCount":0,"image":{"@id":"https:\/\/ggba.swiss\/fr\/la-medtech-aspivix-decroche-eur-195-million-dans-le-cadre-dun-crowdfunding\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2025\/01\/Aspivix-1180x811-1.jpeg","keywords":["Financing","Healthcare","Medical Devices","Medtech"],"articleSection":["Sciences de la vie"],"inLanguage":"fr-FR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/ggba.swiss\/fr\/la-medtech-aspivix-decroche-eur-195-million-dans-le-cadre-dun-crowdfunding\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/ggba.swiss\/fr\/la-medtech-aspivix-decroche-eur-195-million-dans-le-cadre-dun-crowdfunding\/","url":"https:\/\/ggba.swiss\/fr\/la-medtech-aspivix-decroche-eur-195-million-dans-le-cadre-dun-crowdfunding\/","name":"Aspivix d\u00e9croche EUR 1,95 million dans le cadre d'un crowdfunding","isPartOf":{"@id":"https:\/\/staging.ggba.swiss\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/la-medtech-aspivix-decroche-eur-195-million-dans-le-cadre-dun-crowdfunding\/#primaryimage"},"image":{"@id":"https:\/\/ggba.swiss\/fr\/la-medtech-aspivix-decroche-eur-195-million-dans-le-cadre-dun-crowdfunding\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2025\/01\/Aspivix-1180x811-1.jpeg","datePublished":"2025-01-20T09:59:32+00:00","dateModified":"2025-01-20T10:08:24+00:00","author":{"@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"description":"La start-up Aspivix a lev\u00e9 EUR 1,95 million pour permettre la commercialisation de son dispositif gyn\u00e9cologique innovant, Carevix\u2122.","breadcrumb":{"@id":"https:\/\/ggba.swiss\/fr\/la-medtech-aspivix-decroche-eur-195-million-dans-le-cadre-dun-crowdfunding\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ggba.swiss\/fr\/la-medtech-aspivix-decroche-eur-195-million-dans-le-cadre-dun-crowdfunding\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ggba.swiss\/fr\/la-medtech-aspivix-decroche-eur-195-million-dans-le-cadre-dun-crowdfunding\/#primaryimage","url":"https:\/\/ggba.swiss\/app\/uploads\/2025\/01\/Aspivix-1180x811-1.jpeg","contentUrl":"https:\/\/ggba.swiss\/app\/uploads\/2025\/01\/Aspivix-1180x811-1.jpeg","width":1180,"height":811,"caption":"Le dispositif Carevix\u2122 d'Aspivix offre une alternative transformatrice aux outils gyn\u00e9cologiques traditionnels, r\u00e9duisant l'inconfort des patientes tout en faisant progresser le domaine des soins de sant\u00e9 pour les femmes dans le monde entier. | \u00a9 Aspivix"},{"@type":"BreadcrumbList","@id":"https:\/\/ggba.swiss\/fr\/la-medtech-aspivix-decroche-eur-195-million-dans-le-cadre-dun-crowdfunding\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ggba.swiss\/fr\/"},{"@type":"ListItem","position":2,"name":"La medtech Aspivix d\u00e9croche EUR 1,95 million dans le cadre d&#8217;un crowdfunding"}]},{"@type":"WebSite","@id":"https:\/\/staging.ggba.swiss\/en\/#website","url":"https:\/\/staging.ggba.swiss\/en\/","name":"Greater Geneva Bern area","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41","name":"Pierre-Yves Oehrli","url":"https:\/\/ggba.swiss\/fr\/author\/pierre-yves-oehrli\/"}]}},"_links":{"self":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/30316","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/comments?post=30316"}],"version-history":[{"count":1,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/30316\/revisions"}],"predecessor-version":[{"id":30318,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/30316\/revisions\/30318"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media\/30313"}],"wp:attachment":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media?parent=30316"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/categories?post=30316"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/tags?post=30316"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}